Literature DB >> 36033646

An Evaluation of the Coupling Coordination of Technological Innovation System in China's Marine Biopharmaceutical Industry.

Xiumei Fu1, Yangming Zheng1, Chunyu Lin1, Ping Wang2, Changyun Wang3,4.   

Abstract

The marine biopharmaceutical industry (MBI) has been considered as an important part of the blue economy. The high-quality development of this industry depends on the high-level coordinated development of technological innovation system (TIS). In the present study, the coupling mechanism of industrial innovation input subsystem and innovation output subsystem was analyzed for the first time. On this basis, the development level and coupling coordination level of TIS in China's MBI during 2008-2018 were empirically evaluated with the capacity coupling coordination model. Then, the obstacle factors were diagnosed and recognized with the obstacle model. The results showed that the innovation input index fluctuated at a low level in China's MBI. The innovation output index has basically maintained a growth trend, whereas the quality of development was not high. Although the coupling coordination level of TIS showed a positive change as mild disordered → primary coordinated → well-coordinated, the development type of innovation system has changed from the lagging output of innovation into the lagging input of innovation. Insufficient input of innovation factors remained the main obstacle to the improvement of coordination level. Based on the above analysis, suggestions were put forward from the perspectives of policy and fund guarantees to improve the coupling coordination level in China's MBI. © Ocean University of China, Science Press and Springer-Verlag GmbH Germany 2023.

Entities:  

Keywords:  coordinated development; marine biopharmaceutical industry; obstacle factor; subsystem coupling; technological innovation system

Year:  2022        PMID: 36033646      PMCID: PMC9395770          DOI: 10.1007/s11802-023-5310-5

Source DB:  PubMed          Journal:  J Ocean Univ China        ISSN: 1672-5182            Impact factor:   1.179


  6 in total

Review 1.  Emerging biopharmaceuticals from marine actinobacteria.

Authors:  Syed Shams Ul Hassan; Komal Anjum; Syed Qamar Abbas; Najeeb Akhter; Bibi Ibtesam Shagufta; Sayed Asmat Ali Shah; Umber Tasneem
Journal:  Environ Toxicol Pharmacol       Date:  2016-11-22       Impact factor: 4.860

2.  Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2020-03-12       Impact factor: 4.050

Review 3.  Bioactive compounds in seaweeds: An overview of their biological properties and safety.

Authors:  Kannan Rr Rengasamy; Mohamad Fawzi Mahomoodally; Muhammad Zakariyyah Aumeeruddy; Gokhan Zengin; Jianbo Xiao; Doo Hwan Kim
Journal:  Food Chem Toxicol       Date:  2019-11-30       Impact factor: 6.023

4.  Are government subsidies effective in improving innovation efficiency? Based on the research of China's wind power industry.

Authors:  Boqiang Lin; Ranran Luan
Journal:  Sci Total Environ       Date:  2019-12-30       Impact factor: 7.963

Review 5.  Marine natural products.

Authors:  Anthony R Carroll; Brent R Copp; Rohan A Davis; Robert A Keyzers; Michèle R Prinsep
Journal:  Nat Prod Rep       Date:  2022-06-22       Impact factor: 15.111

Review 6.  An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.

Authors:  Verónica Ruiz-Torres; Jose Antonio Encinar; María Herranz-López; Almudena Pérez-Sánchez; Vicente Galiano; Enrique Barrajón-Catalán; Vicente Micol
Journal:  Molecules       Date:  2017-06-23       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.